TRIM59 promotes gliomagenesis by inhibiting tc45 dephosphorylation of STAT3

Youzhou Sang, Yanxin Li, Lina Song, Angel A Alvarez, Weiwei Zhang, Deguan Lv, Jianming Tang, Feng Liu, Zhijie Chang, Shigetsugu Hatakeyama, Bo Hu, Shi-Yuan Cheng, Haizhong Feng

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Aberrant EGFR signaling is a common driver of glioblastoma (GBM) pathogenesis; however, the downstream effectors that sustain this oncogenic pathway remain unclarified. Here we demonstrate that tripartite motif-containing protein 59 (TRIM59) acts as a new downstream effector of EGFR signaling by regulating STAT3 activation in GBM. EGFR signaling led to TRIM59 upregulation through SOX9 and enhanced the interaction between TRIM59 and nuclear STAT3, which prevents STAT3 dephosphorylation by the nuclear form of T-cell protein tyrosine phosphatase (TC45), thereby maintaining transcriptional activation and promoting tumorigenesis. Silencing TRIM59 suppresses cell proliferation, migration, and orthotopic xenograft brain tumor formation of GBM cells and glioma stem cells. Evaluation of GBM patient samples revealed an association between EGFR activation, TRIM59 expression, STAT3 phosphorylation, and poor prognoses. Our study identifies TRIM59 as a new regulator of oncogenic EGFR/STAT3 signaling and as a potential therapeutic target for GBM patients with EGFR activation. Significance: These findings identify a novel component of the EGFR/STAT3 signaling axis in the regulation of glioma tumorigenesis.

Original languageEnglish (US)
Pages (from-to)1792-1804
Number of pages13
JournalCancer Research
Volume78
Issue number7
DOIs
StatePublished - Apr 1 2018

Fingerprint

Glioblastoma
Glioma
Non-Receptor Type 2 Protein Tyrosine Phosphatase
Carcinogenesis
Heterografts
Brain Neoplasms
Transcriptional Activation
Cell Movement
Tripartite Motif Proteins
Up-Regulation
Stem Cells
Phosphorylation
Cell Proliferation
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Sang, Youzhou ; Li, Yanxin ; Song, Lina ; Alvarez, Angel A ; Zhang, Weiwei ; Lv, Deguan ; Tang, Jianming ; Liu, Feng ; Chang, Zhijie ; Hatakeyama, Shigetsugu ; Hu, Bo ; Cheng, Shi-Yuan ; Feng, Haizhong. / TRIM59 promotes gliomagenesis by inhibiting tc45 dephosphorylation of STAT3. In: Cancer Research. 2018 ; Vol. 78, No. 7. pp. 1792-1804.
@article{a92a6050fbbc4178a3bf21447dc43090,
title = "TRIM59 promotes gliomagenesis by inhibiting tc45 dephosphorylation of STAT3",
abstract = "Aberrant EGFR signaling is a common driver of glioblastoma (GBM) pathogenesis; however, the downstream effectors that sustain this oncogenic pathway remain unclarified. Here we demonstrate that tripartite motif-containing protein 59 (TRIM59) acts as a new downstream effector of EGFR signaling by regulating STAT3 activation in GBM. EGFR signaling led to TRIM59 upregulation through SOX9 and enhanced the interaction between TRIM59 and nuclear STAT3, which prevents STAT3 dephosphorylation by the nuclear form of T-cell protein tyrosine phosphatase (TC45), thereby maintaining transcriptional activation and promoting tumorigenesis. Silencing TRIM59 suppresses cell proliferation, migration, and orthotopic xenograft brain tumor formation of GBM cells and glioma stem cells. Evaluation of GBM patient samples revealed an association between EGFR activation, TRIM59 expression, STAT3 phosphorylation, and poor prognoses. Our study identifies TRIM59 as a new regulator of oncogenic EGFR/STAT3 signaling and as a potential therapeutic target for GBM patients with EGFR activation. Significance: These findings identify a novel component of the EGFR/STAT3 signaling axis in the regulation of glioma tumorigenesis.",
author = "Youzhou Sang and Yanxin Li and Lina Song and Alvarez, {Angel A} and Weiwei Zhang and Deguan Lv and Jianming Tang and Feng Liu and Zhijie Chang and Shigetsugu Hatakeyama and Bo Hu and Shi-Yuan Cheng and Haizhong Feng",
year = "2018",
month = "4",
day = "1",
doi = "10.1158/0008-5472.CAN-17-2774",
language = "English (US)",
volume = "78",
pages = "1792--1804",
journal = "Cancer Research",
issn = "0008-5472",
number = "7",

}

Sang, Y, Li, Y, Song, L, Alvarez, AA, Zhang, W, Lv, D, Tang, J, Liu, F, Chang, Z, Hatakeyama, S, Hu, B, Cheng, S-Y & Feng, H 2018, 'TRIM59 promotes gliomagenesis by inhibiting tc45 dephosphorylation of STAT3', Cancer Research, vol. 78, no. 7, pp. 1792-1804. https://doi.org/10.1158/0008-5472.CAN-17-2774

TRIM59 promotes gliomagenesis by inhibiting tc45 dephosphorylation of STAT3. / Sang, Youzhou; Li, Yanxin; Song, Lina; Alvarez, Angel A; Zhang, Weiwei; Lv, Deguan; Tang, Jianming; Liu, Feng; Chang, Zhijie; Hatakeyama, Shigetsugu; Hu, Bo; Cheng, Shi-Yuan; Feng, Haizhong.

In: Cancer Research, Vol. 78, No. 7, 01.04.2018, p. 1792-1804.

Research output: Contribution to journalArticle

TY - JOUR

T1 - TRIM59 promotes gliomagenesis by inhibiting tc45 dephosphorylation of STAT3

AU - Sang, Youzhou

AU - Li, Yanxin

AU - Song, Lina

AU - Alvarez, Angel A

AU - Zhang, Weiwei

AU - Lv, Deguan

AU - Tang, Jianming

AU - Liu, Feng

AU - Chang, Zhijie

AU - Hatakeyama, Shigetsugu

AU - Hu, Bo

AU - Cheng, Shi-Yuan

AU - Feng, Haizhong

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Aberrant EGFR signaling is a common driver of glioblastoma (GBM) pathogenesis; however, the downstream effectors that sustain this oncogenic pathway remain unclarified. Here we demonstrate that tripartite motif-containing protein 59 (TRIM59) acts as a new downstream effector of EGFR signaling by regulating STAT3 activation in GBM. EGFR signaling led to TRIM59 upregulation through SOX9 and enhanced the interaction between TRIM59 and nuclear STAT3, which prevents STAT3 dephosphorylation by the nuclear form of T-cell protein tyrosine phosphatase (TC45), thereby maintaining transcriptional activation and promoting tumorigenesis. Silencing TRIM59 suppresses cell proliferation, migration, and orthotopic xenograft brain tumor formation of GBM cells and glioma stem cells. Evaluation of GBM patient samples revealed an association between EGFR activation, TRIM59 expression, STAT3 phosphorylation, and poor prognoses. Our study identifies TRIM59 as a new regulator of oncogenic EGFR/STAT3 signaling and as a potential therapeutic target for GBM patients with EGFR activation. Significance: These findings identify a novel component of the EGFR/STAT3 signaling axis in the regulation of glioma tumorigenesis.

AB - Aberrant EGFR signaling is a common driver of glioblastoma (GBM) pathogenesis; however, the downstream effectors that sustain this oncogenic pathway remain unclarified. Here we demonstrate that tripartite motif-containing protein 59 (TRIM59) acts as a new downstream effector of EGFR signaling by regulating STAT3 activation in GBM. EGFR signaling led to TRIM59 upregulation through SOX9 and enhanced the interaction between TRIM59 and nuclear STAT3, which prevents STAT3 dephosphorylation by the nuclear form of T-cell protein tyrosine phosphatase (TC45), thereby maintaining transcriptional activation and promoting tumorigenesis. Silencing TRIM59 suppresses cell proliferation, migration, and orthotopic xenograft brain tumor formation of GBM cells and glioma stem cells. Evaluation of GBM patient samples revealed an association between EGFR activation, TRIM59 expression, STAT3 phosphorylation, and poor prognoses. Our study identifies TRIM59 as a new regulator of oncogenic EGFR/STAT3 signaling and as a potential therapeutic target for GBM patients with EGFR activation. Significance: These findings identify a novel component of the EGFR/STAT3 signaling axis in the regulation of glioma tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=85047857701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047857701&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-17-2774

DO - 10.1158/0008-5472.CAN-17-2774

M3 - Article

VL - 78

SP - 1792

EP - 1804

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 7

ER -